Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-02-03 @ 6:27 PM
Study NCT ID:
NCT03875495
Status:
TERMINATED
Last Update Posted:
2022-01-28
First Post:
2019-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
Sponsor:
Genenta Science
Organization: